Table 2.
Laboratory Findings of Patients With Corona Virus Disease 2019 (COVID-19).
| Patients(n = 200) | ICU(n = 29) | Non-ICU (n = 171) | P value | |
|---|---|---|---|---|
| Leucocytes, ×10⁹ /L | 4.4 (3.5−5.7) | 5.76 (4.06−7.82) | 4.37 (3.47−5.48) | 0.01 |
| <3.5 | 45 (22.5 %) | 2 (6.9 %) | 43 (25.1 %) | 0.04 |
| 3.5∼9.5 | 149 (74.5 %) | 25 (86.2 %) | 124 (72.5 %) | 0.11 |
| >9.5 | 6 (3%) | 2 (6.9 %) | 4 (2.3 %) | 0.18 |
| Neutrophils, × 10⁹ /L | 2.92 (2.15−4.07) | 4.8(2.8−6.39) | 2.78(2.1−3.79) | 0.00 |
| Lymphocytes, × 10⁹ /L | 0.91 (0.69−1.22) | 0.73(0.56−0.89) | 0.94 (0.73−1.26) | 0.00 |
| <1.1 | 137 (68.5 %) | 25 (86.2 %) | 112 (65.5 %) | 0.02 |
| Hemoglobin, g/L | 132.0 (17.5) | 123.72 (19.9) | 133.40 (16.7) | 0.00 |
| Platelets, × 10⁹ / L | 154.0 (124.2−189.0) | 145(120.5−177) | 155 (125−192) | 0.23 |
| <125 | 50 (25 %) | 9(31.0 %) | 41 (24.0 %) | 0.41 |
| Activated partial thromboplastin time, s |
34.0(30.3−37.3) | 36.7 (34.0−41.0) | 33.3 (30.1−36.2) | 0.00 |
| Prothrombin time, s | 11.0 (10.5−11.5) | 11.4 (10.6−12.0) | 11 (10.5−11.4) | 0.02 |
| <10.5 | 42/187 (22.5 %) | 5/29 (17.2 %) | 37/158 (23.4 %) | 0.55 |
| D-dimer, ng/mL | 532 (314−768) | 1100 (639−1824) | 497 (306−746) | 0.00 |
| >500 | 119/190(62.6 %) | 25/28 (89.7 %) | 94/162 (58.0 %) | 0.15 |
| Albumin, g/L | 37.88(34.61−40.22) | 32.49 (26.05−34.96) | 38.32 (35.48−40.70) | 0.00 |
| <40 | 144(72 %) | 28 (96.6 %) | 116 (67.8 %) | 0.00 |
| Alanine aminotransferase, U/L | 26 (19−75) | 30 (20.5−76.5) | 26 (19−36) | 0.04 |
| >40 | 44 (22 %) | 12 (41.4 %) | 32 (18.7 %) | 0.00 |
| Aspartate aminotransferase, U/L | 32 (26−39.75) | 41 (33.5−64.5) | 31 (25−39) | 0.00 |
| >35 | 74 (37 %) | 17 (58.6 %) | 57 (33.3 %) | 0.00 |
| Total bilirubin, mmol/L | 12.46 (10.5725−16.085) | 13.18 (10.155−18.285) | 12.45 (10.61−15.92) | 0.58 |
| Potassium, mmol/L | 3.73 (0.42) | 3.90 (0.54) | 3.7 (0.39) | 0.06 |
| Sodium, mmol/L | 137.7 (135.525−139.6) | 136.1 (133.25−139.3) | 137.8(136.2−139.6) | 0.05 |
| Serum creatinine,μmol/L | 64 (52.5−83.1) | 85.6 (65.875−23.275) | 61.8 (50.075−81.45) | 0.00 |
| >81 | 57(28.5 %) | 14 (48.3 %) | 43 (25.1 %) | 0.01 |
| Creatine kinase,IU/L | 92 (61.25−151.75) | 113 (72−192.5) | 88 (61−144) | 0.09 |
| >200 | 31/189 (16.2 %) | 6/27 (22.2 %) | 25/162 (15.4 %) | 0.45 |
| Lactate dehydrogenase, U/L | 229 (187−298) | 342(260.5−468.5) | 217(183−274) | 0.00 |
| >250 | 74/189 (38.5 %) | 22/27(81.5 %) | 52/162(32.1 %) | 0.00 |
| CKMB,IU/L | 11 (9−14) | 12.5 (10−19) | 11 (9−14) | 0.03 |
| >25 | 5/189 (2.6 %) | 3/27 (11.1 %) | 2/162 (1.2 %) | 0.00 |
| Procalcitonin > 0.05 ng/mL | 44/182 (24.2 %) | 23/27 (85.2 %) | 21/155 (13.5 %) | 0.00 |
| C-reactive protein, mg/L | 22.95 (7.45−54.085) | 68.8 (53.47−108.25) | 18.7 (6.3−37.9) | 0.00 |
| >10 | 141/200 (70.5 %) | 29/29 (100 %) | 112/171 (65.5 %) | 0.00 |
| Bilateral involvement of chest CT | 172/200 (86 %) | 28/29 (96.6 %) | 144/171 (84.2 %) | 0.07 |
Data are median (IQR), mean (SD), n (%), or n/N (%), where N is the total number of patients with available data. P values comparing patients with ICU and non-ICU are from t-test, χ² test, Fisher’s exact test, or Mann-Whitney U test NCP = novel coronavirus pneumonia. ICU = intensive care unit.